Given the clinical burden of ALI and the mechanistic interplay among ADAM17-driven cytokine shedding, oxidative and ER stress, and ferroptosis, we hypothesized that pharmacologic inhibition of ADAM17 could mitigate LPS-induced acute liver injury. Here, ADAM17 is linked to acute respiratory distress syndrome.